Portfolio Holdings Detail for ISIN IE000R9FA4A0
Stock Name / Fund iShares S&P 500 ESG UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares III Public Limited Company
Entity Type
Entity LEI 549300PZLRJB7M8H1057
ETF Ticker ESPX(USD) AS
ETF Ticker ESPX(USD) Euronext Amsterdam

Holdings detail for LLY

Stock Name	Eli Lilly and Company
Ticker	LLY(EUR) F
TYPE	Common Stock
Country	Germany
ISIN	US5324571083
LEI	FRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG: Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs: With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About: Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price: Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial: (RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY: The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today: Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock: Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years: Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever: Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years: Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?: Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!: My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks: In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?: Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies: Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats: Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble: Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years: Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade: Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way: Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly: In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis: Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.: Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now: Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks: Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?: Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy: In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares S&P 500 ESG UCITS ETF USD (Acc) LLY holdings

Date	Number of LLY Shares Held	Base Market Value of LLY Shares	Local Market Value of LLY Shares	Change in LLY Shares Held	Change in LLY Base Value	Current Price per LLY Share Held	Previous Price per LLY Share Held
2025-12-11 (Thursday)	16,334	USD 16,487,213	USD 16,487,213	0	USD 257,097	USD 1009.38	USD 993.64
2025-12-10 (Wednesday)	16,334	USD 16,230,116	USD 16,230,116	0	USD 186,535	USD 993.64	USD 982.22
2025-12-09 (Tuesday)	16,334	USD 16,043,581	USD 16,043,581	210	USD -41,560	USD 982.22	USD 997.59
2025-12-08 (Monday)	16,124	USD 16,085,141	USD 16,085,141	140	USD -63,654	USD 997.59	USD 1010.31
2025-12-05 (Friday)	15,984	USD 16,148,795	USD 16,148,795	0	USD -66,813	USD 1010.31	USD 1014.49
2025-12-04 (Thursday)	15,984	USD 16,215,608	USD 16,215,608	140	USD -160,117	USD 1014.49	USD 1033.56
2025-12-03 (Wednesday)	15,844	USD 16,375,725	USD 16,375,725	0	USD -199,000	USD 1033.56	USD 1046.12
2025-12-02 (Tuesday)	15,844	USD 16,574,725	USD 16,574,725	0	USD -186,484	USD 1046.12	USD 1057.89
2025-12-01 (Monday)	15,844	USD 16,761,209	USD 16,761,209	0	USD -278,538	USD 1057.89	USD 1075.47
2025-11-28 (Friday)	15,844	USD 17,039,747	USD 17,039,747	0	USD -457,416	USD 1075.47	USD 1104.34
2025-11-27 (Thursday)	15,844	USD 17,497,163	USD 17,497,163	0	USD 0	USD 1104.34	USD 1104.34
2025-11-26 (Wednesday)	15,844	USD 17,497,163	USD 17,497,163	0	USD -88,726	USD 1104.34	USD 1109.94
2025-11-25 (Tuesday)	15,844	USD 17,585,889	USD 17,585,889	0	USD 630,274	USD 1109.94	USD 1070.16

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE000R9FA4A0

Show aggregate share trades of LLY

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-09 BUY 210 1,012.000 979.180 982.462 EUR 206,317 825.68
2025-12-08 BUY 140 1,014.200 989.000 991.520 EUR 138,813 824.93
2025-12-04 BUY 140 1,014.490* 823.26
2025-11-17 BUY 70 1,032.141 998.302 1,001.685 EUR 70,118 809.80
2025-11-13 SELL -140 1,032.950 1,010.085 1,012.372 EUR -141,732 807.77 Loss of -28,644 on sale
2025-11-07 BUY 210 924.370* 804.55
2025-11-03 BUY 210 901.339 862.680 866.546 EUR 181,975 802.34
2025-10-31 BUY 95 869.910 834.950 838.446 EUR 79,652 802.04
2025-10-17 SELL -140 802.830 804.440 804.279 EUR -112,599 801.24 Loss of -426 on sale
2025-10-15 BUY 140 826.570 830.190 829.828 EUR 116,176 801.01
2025-10-07 BUY 69 843.630 848.540 848.049 EUR 58,515 800.43
2025-09-24 BUY 679 741.850 746.940 746.431 EUR 506,827 802.02
2025-09-16 SELL -210 764.710 770.380 769.813 EUR -161,661 802.69 Profit of 6,905 on sale
2025-09-11 SELL -210 756.280 761.130 760.645 EUR -159,735 803.54 Profit of 9,009 on sale
2025-08-29 BUY 400 732.580 737.420 736.936 EUR 294,774 804.77
2025-08-06 BUY 68 746.370 763.000 761.337 EUR 51,771 806.53
2025-07-31 BUY 279 740.070 766.450 763.812 EUR 213,104 807.45
2025-07-22 BUY 68 776.440 778.290 778.105 EUR 52,911 808.25
2025-07-14 SELL -68 799.340 800.880 800.726 EUR -54,449 809.53 Profit of 598 on sale
2025-07-02 BUY 70 779.280 779.840 779.784 EUR 54,585 811.02
2025-06-30 BUY 401 779.530 785.000 784.453 EUR 314,566 811.24
2025-06-27 BUY 345 775.450 802.500 799.795 EUR 275,929 811.49
2025-06-26 BUY 134 795.120 798.800 798.432 EUR 106,990 811.60
2025-06-18 SELL -67 785.030 790.630 790.070 EUR -52,935 813.05 Profit of 1,540 on sale
2025-06-17 SELL -335 791.240 805.160 803.768 EUR -269,262 813.22 Profit of 3,165 on sale
2025-06-13 BUY 476 819.360 825.000 824.436 EUR 392,432 813.21
2025-06-05 BUY 67 765.680 770.000 769.568 EUR 51,561 814.34
2025-05-30 BUY 402 737.670 745.900 745.077 EUR 299,521 816.44
2025-05-22 SELL -134 715.200 722.190 721.491 EUR -96,680 820.59 Profit of 13,280 on sale
2025-05-19 BUY 670 755.110 758.720 758.359 EUR 508,101 822.65
2025-05-16 BUY 68 757.390 758.870 758.722 EUR 51,593 823.23
2025-05-14 BUY 67 715.560 759.500 755.106 EUR 50,592 825.01
2025-05-01 SELL -67 794.100 850.930 845.247 EUR -56,632 829.39 Loss of -1,063 on sale
2025-04-30 BUY 70 898.950 902.500 902.145 EUR 63,150 828.70
2025-04-23 BUY 201 829.420 846.010 844.351 EUR 169,715 826.69
2025-04-17 BUY 67 839.960 858.000 856.196 EUR 57,365 826.49
2025-04-11 BUY 285 732.410 735.840 735.497 EUR 209,617 830.21
2025-04-07 SELL -469 723.730 748.000 745.573 EUR -349,674 834.92 Profit of 41,905 on sale
2025-04-04 SELL -603 738.210 768.270 765.264 EUR -461,454 836.09 Profit of 42,707 on sale
2025-03-31 SELL -50 825.910 828.010 827.800 EUR -41,390 836.82 Profit of 451 on sale
2025-03-21 SELL -3 837.570 850.430 849.144 EUR -2,547 836.76 Loss of -37 on sale
2025-03-18 SELL -268 822.510 836.290 834.912 EUR -223,756 836.87 Profit of 526 on sale
2025-03-17 SELL -664 824.760 829.000 828.576 EUR -550,174 837.05 Profit of 5,625 on sale
2025-03-13 SELL -134 801.650 821.110 819.164 EUR -109,768 837.91 Profit of 2,513 on sale
2025-03-11 BUY 247 824.060 832.350 831.521 EUR 205,386 838.37
2025-03-10 SELL -67 829.760 863.190 859.847 EUR -57,610 838.50 Loss of -1,430 on sale
2025-03-05 SELL -201 929.720 930.490 930.413 EUR -187,013 835.33 Loss of -19,112 on sale
2025-03-03 SELL -67 929.720 935.630 935.039 EUR -62,648 832.49 Loss of -6,871 on sale
2025-02-21 SELL -248 873.680 894.400 892.328 EUR -221,297 825.04 Loss of -16,688 on sale
2025-02-14 SELL -268 844.270 873.500 870.577 EUR -233,315 821.76 Loss of -13,084 on sale
2025-02-12 SELL -335 872.970 877.780 877.299 EUR -293,895 819.60 Loss of -19,329 on sale
2025-02-10 BUY 67 868.880 880.000 878.888 EUR 58,885 817.50
2025-02-05 BUY 945 842.180 846.900 846.428 EUR 799,874 814.20
2025-02-03 BUY 134 810.430 817.960 817.207 EUR 109,506 814.00
2025-01-31 BUY 603 811.080 827.350 825.723 EUR 497,911 814.07
2025-01-29 BUY 335 804.080 809.120 808.616 EUR 270,886 814.10
2025-01-28 BUY 62 804.990 816.150 815.034 EUR 50,532 814.35
2025-01-24 BUY 67 785.410 789.290 788.902 EUR 52,856 815.38
2024-12-09 BUY 62 803.580 823.700 821.688 EUR 50,945 817.85
2024-12-06 BUY 858 826.710 841.000 839.571 EUR 720,352 817.55
2024-12-03 BUY 264 813.330 817.130 816.750 EUR 215,622 816.95
2024-12-02 BUY 66 799.800 805.350 804.795 EUR 53,116 817.61
2024-11-29 SELL -79 795.350 800.330 799.832 EUR -63,187 818.50 Profit of 1,475 on sale
2024-11-08 BUY 462 831.540 847.270 845.697 EUR 390,712 855.95
2024-10-31 SELL -33 829.740 853.500 851.124 EUR -28,087 893.57 Profit of 1,401 on sale
2024-10-30 BUY 66 846.830 860.500 859.133 EUR 56,703 900.25
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-09	BUY	210	1,012.000	979.180	982.462	EUR 206,317	825.68
2025-12-08	BUY	140	1,014.200	989.000	991.520	EUR 138,813	824.93
2025-12-04	BUY	140			1,014.490*		823.26
2025-11-17	BUY	70	1,032.141	998.302	1,001.685	EUR 70,118	809.80
2025-11-13	SELL	-140	1,032.950	1,010.085	1,012.372	EUR -141,732	807.77 Loss of -28,644 on sale
2025-11-07	BUY	210			924.370*		804.55
2025-11-03	BUY	210	901.339	862.680	866.546	EUR 181,975	802.34
2025-10-31	BUY	95	869.910	834.950	838.446	EUR 79,652	802.04
2025-10-17	SELL	-140	802.830	804.440	804.279	EUR -112,599	801.24 Loss of -426 on sale
2025-10-15	BUY	140	826.570	830.190	829.828	EUR 116,176	801.01
2025-10-07	BUY	69	843.630	848.540	848.049	EUR 58,515	800.43
2025-09-24	BUY	679	741.850	746.940	746.431	EUR 506,827	802.02
2025-09-16	SELL	-210	764.710	770.380	769.813	EUR -161,661	802.69 Profit of 6,905 on sale
2025-09-11	SELL	-210	756.280	761.130	760.645	EUR -159,735	803.54 Profit of 9,009 on sale
2025-08-29	BUY	400	732.580	737.420	736.936	EUR 294,774	804.77
2025-08-06	BUY	68	746.370	763.000	761.337	EUR 51,771	806.53
2025-07-31	BUY	279	740.070	766.450	763.812	EUR 213,104	807.45
2025-07-22	BUY	68	776.440	778.290	778.105	EUR 52,911	808.25
2025-07-14	SELL	-68	799.340	800.880	800.726	EUR -54,449	809.53 Profit of 598 on sale
2025-07-02	BUY	70	779.280	779.840	779.784	EUR 54,585	811.02
2025-06-30	BUY	401	779.530	785.000	784.453	EUR 314,566	811.24
2025-06-27	BUY	345	775.450	802.500	799.795	EUR 275,929	811.49
2025-06-26	BUY	134	795.120	798.800	798.432	EUR 106,990	811.60
2025-06-18	SELL	-67	785.030	790.630	790.070	EUR -52,935	813.05 Profit of 1,540 on sale
2025-06-17	SELL	-335	791.240	805.160	803.768	EUR -269,262	813.22 Profit of 3,165 on sale
2025-06-13	BUY	476	819.360	825.000	824.436	EUR 392,432	813.21
2025-06-05	BUY	67	765.680	770.000	769.568	EUR 51,561	814.34
2025-05-30	BUY	402	737.670	745.900	745.077	EUR 299,521	816.44
2025-05-22	SELL	-134	715.200	722.190	721.491	EUR -96,680	820.59 Profit of 13,280 on sale
2025-05-19	BUY	670	755.110	758.720	758.359	EUR 508,101	822.65
2025-05-16	BUY	68	757.390	758.870	758.722	EUR 51,593	823.23
2025-05-14	BUY	67	715.560	759.500	755.106	EUR 50,592	825.01
2025-05-01	SELL	-67	794.100	850.930	845.247	EUR -56,632	829.39 Loss of -1,063 on sale
2025-04-30	BUY	70	898.950	902.500	902.145	EUR 63,150	828.70
2025-04-23	BUY	201	829.420	846.010	844.351	EUR 169,715	826.69
2025-04-17	BUY	67	839.960	858.000	856.196	EUR 57,365	826.49
2025-04-11	BUY	285	732.410	735.840	735.497	EUR 209,617	830.21
2025-04-07	SELL	-469	723.730	748.000	745.573	EUR -349,674	834.92 Profit of 41,905 on sale
2025-04-04	SELL	-603	738.210	768.270	765.264	EUR -461,454	836.09 Profit of 42,707 on sale
2025-03-31	SELL	-50	825.910	828.010	827.800	EUR -41,390	836.82 Profit of 451 on sale
2025-03-21	SELL	-3	837.570	850.430	849.144	EUR -2,547	836.76 Loss of -37 on sale
2025-03-18	SELL	-268	822.510	836.290	834.912	EUR -223,756	836.87 Profit of 526 on sale
2025-03-17	SELL	-664	824.760	829.000	828.576	EUR -550,174	837.05 Profit of 5,625 on sale
2025-03-13	SELL	-134	801.650	821.110	819.164	EUR -109,768	837.91 Profit of 2,513 on sale
2025-03-11	BUY	247	824.060	832.350	831.521	EUR 205,386	838.37
2025-03-10	SELL	-67	829.760	863.190	859.847	EUR -57,610	838.50 Loss of -1,430 on sale
2025-03-05	SELL	-201	929.720	930.490	930.413	EUR -187,013	835.33 Loss of -19,112 on sale
2025-03-03	SELL	-67	929.720	935.630	935.039	EUR -62,648	832.49 Loss of -6,871 on sale
2025-02-21	SELL	-248	873.680	894.400	892.328	EUR -221,297	825.04 Loss of -16,688 on sale
2025-02-14	SELL	-268	844.270	873.500	870.577	EUR -233,315	821.76 Loss of -13,084 on sale
2025-02-12	SELL	-335	872.970	877.780	877.299	EUR -293,895	819.60 Loss of -19,329 on sale
2025-02-10	BUY	67	868.880	880.000	878.888	EUR 58,885	817.50
2025-02-05	BUY	945	842.180	846.900	846.428	EUR 799,874	814.20
2025-02-03	BUY	134	810.430	817.960	817.207	EUR 109,506	814.00
2025-01-31	BUY	603	811.080	827.350	825.723	EUR 497,911	814.07
2025-01-29	BUY	335	804.080	809.120	808.616	EUR 270,886	814.10
2025-01-28	BUY	62	804.990	816.150	815.034	EUR 50,532	814.35
2025-01-24	BUY	67	785.410	789.290	788.902	EUR 52,856	815.38
2024-12-09	BUY	62	803.580	823.700	821.688	EUR 50,945	817.85
2024-12-06	BUY	858	826.710	841.000	839.571	EUR 720,352	817.55
2024-12-03	BUY	264	813.330	817.130	816.750	EUR 215,622	816.95
2024-12-02	BUY	66	799.800	805.350	804.795	EUR 53,116	817.61
2024-11-29	SELL	-79	795.350	800.330	799.832	EUR -63,187	818.50 Profit of 1,475 on sale
2024-11-08	BUY	462	831.540	847.270	845.697	EUR 390,712	855.95
2024-10-31	SELL	-33	829.740	853.500	851.124	EUR -28,087	893.57 Profit of 1,401 on sale
2024-10-30	BUY	66	846.830	860.500	859.133	EUR 56,703	900.25

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	432,038	935	1,319,853	32.7%
2025-09-18	547,818	126	1,290,147	42.5%
2025-09-17	437,337	427	1,166,204	37.5%
2025-09-16	532,698	1,829	1,463,374	36.4%
2025-09-15	424,979	701	1,071,487	39.7%
2025-09-12	267,121	172	826,802	32.3%
2025-09-11	249,803	1,484	850,461	29.4%
2025-09-10	415,442	1,025	989,008	42.0%
2025-09-09	559,805	667	1,270,800	44.1%
2025-09-08	856,018	4,682	1,937,447	44.2%
2025-09-05	679,276	1,050	1,405,239	48.3%
2025-09-04	337,491	53	982,751	34.3%
2025-09-03	214,691	496	766,157	28.0%
2025-09-02	430,477	2,977	1,131,908	38.0%
2025-08-29	357,538	602	889,509	40.2%
2025-08-28	433,687	1,099	1,113,568	38.9%
2025-08-27	860,715	6,009	1,681,353	51.2%
2025-08-26	1,548,460	12,105	2,955,348	52.4%
2025-08-25	566,454	3,586	1,323,249	42.8%
2025-08-22	749,615	1,957	1,460,713	51.3%
2025-08-21	651,639	223	1,570,067	41.5%
2025-08-20	679,554	2,698	1,870,241	36.3%
2025-08-19	787,909	935	2,788,740	28.3%
2025-08-18	756,143	1,095	1,727,603	43.8%
2025-08-15	1,814,721	836	3,422,260	53.0%
2025-08-14	1,852,940	5,382	3,602,829	51.4%
2025-08-13	1,254,225	3,473	2,774,100	45.2%
2025-08-12	990,110	3,190	2,845,896	34.8%
2025-08-11	1,290,063	1,615	5,196,302	24.8%
2025-08-08	2,448,706	300,870	6,239,830	39.2%
2025-08-07	4,197,951	489,618	10,364,294	40.5%
2025-08-06	440,144	1,120	1,811,262	24.3%
2025-08-05	331,460	921	993,178	33.4%
2025-08-04	474,905	1,408	1,273,995	37.3%
2025-08-01	530,569	7,139	1,882,098	28.2%
2025-07-31	882,506	3,670	2,110,030	41.8%
2025-07-30	745,614	392	1,827,435	40.8%
2025-07-29	1,081,849	571	2,607,245	41.5%
2025-07-28	304,841	7,460	1,004,032	30.4%
2025-07-25	365,417	265	1,055,273	34.6%
2025-07-24	321,799	762	1,167,147	27.6%
2025-07-23	485,719	3,471	1,044,919	46.5%
2025-07-22	241,098	3,036	874,717	27.6%
2025-07-21	418,014	854	1,180,445	35.4%
2025-07-18	623,498	651	1,225,333	50.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.